MY100519A - Method and composition for the treatment of chronic obstructive pulmonary disease - Google Patents

Method and composition for the treatment of chronic obstructive pulmonary disease

Info

Publication number
MY100519A
MY100519A MYPI87001843A MYPI19871843A MY100519A MY 100519 A MY100519 A MY 100519A MY PI87001843 A MYPI87001843 A MY PI87001843A MY PI19871843 A MYPI19871843 A MY PI19871843A MY 100519 A MY100519 A MY 100519A
Authority
MY
Malaysia
Prior art keywords
chronic obstructive
obstructive pulmonary
treatment
composition
pulmonary disease
Prior art date
Application number
MYPI87001843A
Inventor
Sackner Marvin
Ahmed Tahir
Original Assignee
Key Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Key Pharma filed Critical Key Pharma
Publication of MY100519A publication Critical patent/MY100519A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

CHRONIC OBSTRUCTIVE PULMONARY DISEASES ARE TREATED WITH A BETA ADRENERGIC AGONIST AND A CALCIUM CHANNEL BLOCKER. THE CALCIUM CHANNEL BLOCKER INCREASES MAGNITUDE OF DILATION AND THE EFFECTIVE TREATMENT TIME OF THE BETA-ADRENERGIC AGONIST. (FIG. 1)
MYPI87001843A 1985-07-02 1987-09-22 Method and composition for the treatment of chronic obstructive pulmonary disease MY100519A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75111485A 1985-07-02 1985-07-02

Publications (1)

Publication Number Publication Date
MY100519A true MY100519A (en) 1990-10-30

Family

ID=25020531

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI87001843A MY100519A (en) 1985-07-02 1987-09-22 Method and composition for the treatment of chronic obstructive pulmonary disease

Country Status (8)

Country Link
EP (1) EP0231266A1 (en)
JP (1) JPS63500243A (en)
KR (1) KR890004691B1 (en)
AU (1) AU601695B2 (en)
DK (1) DK103087D0 (en)
FI (1) FI870731A (en)
MY (1) MY100519A (en)
WO (1) WO1987000047A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4430128A1 (en) * 1994-08-25 1996-02-29 Hoechst Ag Combination preparation with immunosuppressive, cardiovascular and cerebral effects
CA2687013C (en) * 2009-12-03 2018-09-04 Kenneth W. Adams Method and composition for treatment and prevention of broad spectrum virus ailments
TR201007251A2 (en) * 2010-09-01 2012-03-21 Bi̇lgi̇ç Mahmut Calcium channel blocker formulation.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3440881A1 (en) * 1984-11-06 1986-05-15 Schering AG, Berlin und Bergkamen, 1000 Berlin PHARMACEUTICAL COMPOSITION, ITS PRODUCTION AND USE

Also Published As

Publication number Publication date
AU601695B2 (en) 1990-09-20
FI870731A0 (en) 1987-02-20
DK103087A (en) 1987-02-27
JPS63500243A (en) 1988-01-28
AU6141486A (en) 1987-01-30
FI870731A (en) 1987-02-20
EP0231266A1 (en) 1987-08-12
WO1987000047A1 (en) 1987-01-15
KR890004691B1 (en) 1989-11-25
DK103087D0 (en) 1987-02-27
KR870700349A (en) 1987-12-28

Similar Documents

Publication Publication Date Title
BR9306226A (en) Composition of wound healing and treatment of fibrotic disorders and method for its preparation
BR8107250A (en) PROCESS FOR THE DISINTEGRATION AND HYDROGENATED TREATMENT OF A HYDROCARBON FEEDING LOAD
EP0152919A3 (en) Apparatus for the air-entangling of several running yarns
GB2206788B (en) 5 ht-3 antagonist for the treatment or reduction of dependence
PT79962A (en) Process and apparatus for inhibiting nasal secretions
DE3561295D1 (en) Method for the treatment of packing material and the material treated accordingly
JPS57198800A (en) Composition for keratin fiber treatment and treating process
ZA852316B (en) Pharmaceutical composition and method for treatment or prophylaxis of cardiac disorders
AU571184B2 (en) Compositions and methods for treating circulation disorders using protoberberines
ES520218A0 (en) A PROCEDURE FOR THE PREPARATION OF NEW 2,3-DIARIL-5-HALOTIOFEN.
MY100519A (en) Method and composition for the treatment of chronic obstructive pulmonary disease
KR100226082B1 (en) Arylalkyl esters of 4,5-dihydroxy-9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic acid having therapeutical activity
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
EP0065963A4 (en) Compounds and method for treatment or prophylaxis of cardiac disorders.
EG15911A (en) Method for treating cardiac disorders with n-(aryloxyalkyl)-n'-(aminoalkyl)ureas
ZA827772B (en) A composition and method for treatment of bites, stings and wounds
DE3573740D1 (en) Method and composition for the treatment of pipelines
SE8800461L (en) PHARMACEUTICAL COMPOSITION
GB2163050B (en) Method of treating or preventing diseases using 1,4-dihydropyridines
FR2522657B1 (en) COMPOSITION FOR TREATING A KERATINIC SUBSTRATE COMPRISING CHEMICALLY MODIFIED PROTEINS AND PROCESS FOR THE PREPARATION OF SAID PROTEINS
IT8567398A1 (en) PROCEDURE FOR QUALITATIVE AND QUANTITATIVE ANALYSIS OF EPSILON INTERFERON.
HUT44436A (en) Process for preparing pharmaceuticals comprising 9alpha, 11beta-dichlor-16alpha-methyl-21-(dicyclohexylmethyloxy-carbonyloxy)-pregno-1,4-dien-3,20-dione
ZA852151B (en) Process and apparatus for the manufacture of activated form coke
DE3560747D1 (en) Substituted 2-(1-amino-akylidenyl)1,3-indane diones, process for their preparation and their therapeutical use
AU9051882A (en) Method and composition for treating a patient suffering from interferon-susceptible disorders